Immunotherapy: An Answer for Cancer?C.V.Patel1 and V.C.Patel2*
- *Corresponding Author:
- Vitthal C. Patel
Speciality Medical Consultant
Department of Surgery
V.N.Desai Municipal General Hospital, Mumbai, India
Tel : +919820735901
E-mail: [email protected]
Received Date: May 03, 2017; Accepted Date: May 16, 2017; Published Date: May 22, 2017
Citation: C.V.Patel and V.C.Patel (2017) Immunotherapy: An Answer for Cancer?. J Cancer Clin Trials 2:131.
Copyright: © 2017 Patel C.V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: Conventional treatment offers no solution to advanced cancer patients in developing countries like India. The aim was to find out if the history of Indian and world medicine reveals any answers for such patients.
Methods: The evidence based therapies tried in clinical cases were recorded from world literature on oncology. The only selection criterion was advance cancer patients in whom conventional treatment was tried and failed.
Results: The parameters of results were mainly a) palliation of symptoms b) increase in life span c) disease free survival. The methods tried in literature were used in our patients and results of original authors and our results were compared and recorded. Pathophysiology of each method was discussed independently.
Conclusions: Best results were obtained where conventional destructive methods were complimented with boost to patient’s immunity. Principles of Dr Jenner’s vaccine therapy were utilised. Though histologically, patients may suffer from one pathology (i.e. Gastric cancer), each patient may give different immunological response to immunotherapy. Hence each patient was immunological stimulated against his own tumour by totally or partially destroying his tumour in situ with physical agents like patients own urine, or heat, anoxia and powerful allergens from plant extracts. Our survival rates are 3% over 10 years of disease control. In other 97% patients, about 30% had substantial palliation. Rest died at home shortly and follow up was not possible.